| Year |
Citation |
Score |
| 2021 |
Hsu YC, Tseng CH, Su TH, Kao JH, Nguyen MH. Pooling data to assess risks and benefits of discontinuing nucleos(t)ide analogs in patients with chronic hepatitis B: challenges and opportunities. Gut. PMID 34670810 DOI: 10.1136/gutjnl-2021-326232 |
0.349 |
|
| 2021 |
Cheng HR, Yang HC, Lin SR, Yang TY, Lin YY, Su TH, Tseng TC, Liu CJ, Kao JH. Correction to: Combined viral quasispecies diversity and hepatitis B core-related antigen predict off-nucleos(t)ide analog durability in HBeAg-negative patients. Hepatology International. PMID 34562189 DOI: 10.1007/s12072-021-10245-z |
0.376 |
|
| 2021 |
Su TH, Peng CY, Chang SH, Tseng TC, Liu CJ, Chen CL, Liu CH, Yang HC, Chen PJ, Kao JH. Serum PIVKA-II and alpha-fetoprotein at virological remission predicts hepatocellular carcinoma in chronic hepatitis B related cirrhosis. Journal of the Formosan Medical Association = Taiwan Yi Zhi. PMID 34452785 DOI: 10.1016/j.jfma.2021.08.003 |
0.308 |
|
| 2021 |
Chen SH, Lai HC, Su WP, Kao JT, Chuang PH, Hsu WF, Wang HW, Tsai TY, Chen HY, Peng CY. Liver and Spleen Stiffness Surveillance Through Elastography During and After Direct-Acting Antiviral Therapy in Patients With Chronic Hepatitis C. Journal of Ultrasound in Medicine : Official Journal of the American Institute of Ultrasound in Medicine. PMID 34415630 DOI: 10.1002/jum.15806 |
0.392 |
|
| 2021 |
Yeh ML, Hung CH, Tseng KC, Lai HC, Chen CY, Kuo HT, Wang JH, Chen JJ, Lee PL, Chien RN, Yang CC, Lo GH, Tai CM, Lin CW, Kao JH, et al. Long-term outcome of liver complications in patients with chronic HBV/HCV co-infection after antiviral therapy: a real-world nationwide study on Taiwanese Chronic Hepatitis C Cohort (T-COACH). Hepatology International. PMID 34365587 DOI: 10.1007/s12072-021-10220-8 |
0.445 |
|
| 2021 |
Kao JH, Jeng WJ, Ning Q, Su TH, Tseng TC, Ueno Y, Yuen MF. APASL guidance on stopping nucleos(t)ide analogues in chronic hepatitis B patients. Hepatology International. PMID 34297329 DOI: 10.1007/s12072-021-10223-5 |
0.398 |
|
| 2021 |
Liu CH, Chen CY, Su WW, Liu CJ, Lo CC, Huang KJ, Chen JJ, Tseng KC, Chang CY, Peng CY, Shih YL, Huang CS, Kao WY, Yang SS, Tsai MC, ... Kao JH, et al. Sofosbuvir/velpatasvir plus ribavirin for Child-Pugh B and Child-Pugh C hepatitis C virus-related cirrhosis. Clinical and Molecular Hepatology. PMID 34255961 DOI: 10.3350/cmh.2021.0155 |
0.392 |
|
| 2021 |
Liu CH, Chen PY, Chen JJ, Lo CC, Su WW, Tseng KC, Liu CJ, Huang CS, Huang KJ, Yang SS, Peng CY, Tsai MC, Kao WY, Chang CY, Shih YL, ... Kao JH, et al. Sofosbuvir/velpatasvir for patients with chronic hepatitis C virus infection and compensated liver disease: real-world data in Taiwan. Hepatology International. PMID 33677787 DOI: 10.1007/s12072-021-10158-x |
0.41 |
|
| 2021 |
Chen CY, Huang CF, Cheng PN, Tseng KC, Lo CC, Kuo HT, Huang YH, Tai CM, Peng CY, Bair MJ, Chen CH, Yeh ML, Lin CL, Lin CY, Lee PL, ... Kao JH, et al. Factors associated with treatment failure of direct-acting antivirals for chronic hepatitis C - a real-world nationwide HCV Registry Program (TACR) in Taiwan. Liver International : Official Journal of the International Association For the Study of the Liver. PMID 33655714 DOI: 10.1111/liv.14849 |
0.393 |
|
| 2021 |
Hsieh MH, Bair MJ, Tsai PC, Tseng KC, Lo CC, Chen CY, Kuo HT, Hung CH, Lai HC, Peng CY, Wang JH, Chen JJ, Lee PL, Chien RN, Yang CC, ... Kao JH, et al. Long-term risk of end stage renal diseases with maintenance dialysis among chronic hepatitis C patients after antiviral therapy in Taiwan. Journal of Gastroenterology and Hepatology. PMID 33624849 DOI: 10.1111/jgh.15469 |
0.326 |
|
| 2021 |
Wu JW, Kao JH, Tseng TC. Three Heads are Better than Two: HBcrAg as a New Predictor of HBV-related HCC. Clinical and Molecular Hepatology. PMID 33618507 DOI: 10.3350/cmh.2021.0012 |
0.377 |
|
| 2021 |
Tseng TC, Choi J, Nguyen MH, Peng CY, Siakavellas S, Papatheodoridis G, Wang CC, Lim YS, Lai HC, Trinh HN, Wong C, Wong C, Zhang J, Li J, Kao JH. One-year Fibrosis-4 index helps identify minimal HCC risk in non-cirrhotic chronic hepatitis B patients with antiviral treatment. Hepatology International. PMID 33547557 DOI: 10.1007/s12072-020-10124-z |
0.387 |
|
| 2021 |
Tseng TC, Liu CJ, Yang WT, Hsu CY, Hong CM, Su TH, Tsai CH, Chen CL, Yang HC, Liu CH, Chen HH, Chen PJ, Kao JH. Serum hepatitis B core-related antigen level stratifies risk of disease progression in chronic hepatitis B patients with intermediate viral load. Alimentary Pharmacology & Therapeutics. PMID 33465271 DOI: 10.1111/apt.16266 |
0.469 |
|
| 2021 |
Liu CH, Chen CY, Su WW, Tseng KC, Lo CC, Liu CJ, Chen JJ, Peng CY, Shih YL, Yang SS, Huang CS, Huang KJ, Chang CY, Tsai MC, Kao WY, ... Kao JH, et al. Sofosbuvir/velpatasvir with or without low-dose ribavirin for patients with chronic hepatitis C virus infection and severe renal impairment. Gut. PMID 33408122 DOI: 10.1136/gutjnl-2020-323569 |
0.326 |
|
| 2021 |
Liu M, Tseng TC, Jun DW, Yeh ML, Trinh H, Wong GLH, Chen CH, Peng CY, Kim SE, Oh H, Kwak MS, Cheung M, Toyoda H, Hsu YC, Jeong JY, ... Kao JH, et al. Transition rates to cirrhosis and liver cancer by age, gender, disease and treatment status in Asian chronic hepatitis B patients. Hepatology International. PMID 33394321 DOI: 10.1007/s12072-020-10113-2 |
0.359 |
|
| 2020 |
Su TH, Kao JH. Withdrawal of Nucleos(t)ide Analogues in Hepatitis B e Antigen-Negative Patients: An Asian Perspective. Clinical Liver Disease. 16: 244-248. PMID 33489096 DOI: 10.1002/cld.950 |
0.338 |
|
| 2020 |
Tsai PC, Chen CY, Kuo HT, Hung CH, Tseng KC, Lai HC, Peng CY, Wang JH, Chen JJ, Lee PL, Chien RN, Yang CC, Lo GH, Kao JH, Liu CJ, et al. Successful Antiviral Therapy Reduces Risk of Schizophrenia Among Chronic Hepatitis C Patients: A Nationwide Real-World Taiwanese Cohort (T-COACH). Open Forum Infectious Diseases. 7: ofaa397. PMID 33376753 DOI: 10.1093/ofid/ofaa397 |
0.349 |
|
| 2020 |
Chen CL, Kuo MJ, Yen AM, Yang WS, Kao JH, Chen PJ, Chen HH. Gender Difference in the Association Between Metabolic Factors and Hepatocellular Carcinoma. Jnci Cancer Spectrum. 4: pkaa036. PMID 33134821 DOI: 10.1093/jncics/pkaa036 |
0.35 |
|
| 2020 |
Wang CC, Tseng KC, Tzeng IS, Kao JH. The impact of cytokine change after hepatitis C virus clearance by direct antiviral agents on the risk of hepatocellular carcinoma. Journal of the Formosan Medical Association = Taiwan Yi Zhi. PMID 33129621 DOI: 10.1016/j.jfma.2020.10.015 |
0.319 |
|
| 2020 |
Yeo YH, Tseng TC, Hosaka T, Cunningham C, Fung JYY, Ho HJ, Kwak MS, Trinh HN, Ungtrakul T, Yu ML, Kobayashi M, Le AK, Henry L, Li J, Zhang J, ... Kao JH, et al. Incidence, Factors, and Patient-Level Data for Spontaneous HBsAg Seroclearance: A Cohort Study of 11,264 Patients. Clinical and Translational Gastroenterology. 11: e00196. PMID 33094953 DOI: 10.14309/ctg.0000000000000196 |
0.356 |
|
| 2020 |
Yu ML, Tsai WL, Chu CJ, Kao JH. Characteristics of patients with hepatitis C virus infection and antiviral treatment initiation in Taiwan: The MOSAIC study. The Kaohsiung Journal of Medical Sciences. PMID 33089964 DOI: 10.1002/kjm2.12317 |
0.361 |
|
| 2020 |
Kao JH, Hu TH, Jia J, Kurosaki M, Lim YS, Lin HC, Sinn DH, Tanaka Y, Wai-Sun Wong V, Yuen MF. East Asia expert opinion on treatment initiation for chronic hepatitis B. Alimentary Pharmacology & Therapeutics. PMID 32951256 DOI: 10.1111/Apt.16097 |
0.356 |
|
| 2020 |
Chen PJ, Kao JH, Liu CJ, Yang HC. In memoriam: Dr. Ding-Shinn Chen, 1943-2020. Hepatology (Baltimore, Md.). PMID 32767845 DOI: 10.1002/Hep.31505 |
0.394 |
|
| 2020 |
Cox AL, El-Sayed MH, Kao JH, Lazarus JV, Lemoine M, Lok AS, Zoulim F. Progress towards elimination goals for viral hepatitis. Nature Reviews. Gastroenterology & Hepatology. PMID 32704164 DOI: 10.1038/s41575-020-0332-6 |
0.421 |
|
| 2020 |
Lin CL, Tseng KC, Chen KY, Liao LY, Kao JH. Factors predicting outcomes of hepatitis B-related cirrhosis patients with long-term antiviral therapy. Journal of the Formosan Medical Association = Taiwan Yi Zhi. PMID 32653388 DOI: 10.1016/j.jfma.2020.07.003 |
0.533 |
|
| 2020 |
Liu CH, Su TH, Liu CJ, Chen PJ, Chen DS, Kao JH. Sofosbuvir/velpatasvir/voxilaprevir plus ribavirin for chronic hepatitis C patients with direct acting antiviral failures: Implications for viral elimination in Taiwan. Journal of the Formosan Medical Association = Taiwan Yi Zhi. PMID 32553687 DOI: 10.1016/j.jfma.2020.06.013 |
0.348 |
|
| 2020 |
Liu CH, Peng CY, Fang YJ, Kao WY, Yang SS, Lin CK, Lai HC, Su WP, Fang SU, Chang CC, Su TH, Liu CJ, Chen PJ, Chen DS, Kao JH. Elbasvir/grazoprevir for hepatitis C virus genotype 1b East-Asian patients receiving hemodialysis. Scientific Reports. 10: 9180. PMID 32513953 DOI: 10.1038/s41598-020-66182-8 |
0.374 |
|
| 2020 |
Su HJ, Kao JH, Tseng TC, Yang HC, Su TH, Chen PJ, Liu CJ. Pathologic findings of patients with nonalcoholic fatty liver disease and the impact of concurrent hepatitis B virus infection in Taiwan. Journal of the Formosan Medical Association = Taiwan Yi Zhi. PMID 32499209 DOI: 10.1016/J.Jfma.2020.05.027 |
0.423 |
|
| 2020 |
Huang SC, Yang HC, Kao JH. Hepatitis B Reactivation: Diagnosis and Management. Expert Review of Gastroenterology & Hepatology. PMID 32448008 DOI: 10.1080/17474124.2020.1774364 |
0.412 |
|
| 2020 |
Tseng TC, Peng CY, Hsu YC, Su TH, Wang CC, Liu CJ, Yang HC, Yang WT, Lin CH, Yu ML, Lai HC, Tanaka Y, Nguyen MH, Liu CH, Chen PJ, ... Kao JH, et al. Baseline Mac-2 Binding Protein Glycosylation Isomer Level Stratifies Risks of Hepatocellular Carcinoma in Chronic Hepatitis B Patients with Oral Antiviral Therapy. Liver Cancer. 9: 207-220. PMID 32399434 DOI: 10.1159/000504650 |
0.376 |
|
| 2020 |
Chang WY, Chiu YC, Chiu FW, Hsu YC, Tseng TC, Cheng PN, Yang SS, Liu CJ, Su TH, Yang HC, Liu CH, Chen PJ, Chen DS, Kao JH. High Risk of clinical relapse in HBV-infected patients after cessation of prophylactic antiviral therapy for rituximab-containing chemotherapy. The Journal of Infectious Diseases. PMID 32396638 DOI: 10.1093/Infdis/Jiaa256 |
0.407 |
|
| 2020 |
Lin CL, Kao JH. Hepatitis B: Immunization and Impact on Natural History and Cancer Incidence. Gastroenterology Clinics of North America. 49: 201-214. PMID 32389359 DOI: 10.1016/j.gtc.2020.01.010 |
0.582 |
|
| 2020 |
Yu ML, Chen PJ, Dai CY, Hu TH, Huang CF, Huang YH, Hung CH, Lin CY, Liu CH, Liu CJ, Peng CY, Lin HC, Kao JH, Chuang WL. 2020 Taiwan consensus statement on the management of hepatitis C: part (I) general population. Journal of the Formosan Medical Association = Taiwan Yi Zhi. PMID 32359879 DOI: 10.1016/j.jfma.2020.04.003 |
0.375 |
|
| 2020 |
Yu ML, Chen PJ, Dai CY, Hu TH, Huang CF, Huang YH, Hung CH, Lin CY, Liu CH, Liu CJ, Peng CY, Lin HC, Kao JH, Chuang WL. 2020 Taiwan consensus statement on the management of hepatitis C: Part (II) special populations. Journal of the Formosan Medical Association = Taiwan Yi Zhi. PMID 32354689 DOI: 10.1016/j.jfma.2020.04.002 |
0.406 |
|
| 2020 |
Hsu CS, Liu WL, Li Q, Lowey B, Hertz L, Chao YC, Liang TJ, Chen DS, Kao JH. Hepatitis C virus genotypes 1-3 infections regulate lipogenic signaling and suppress cholesterol biosynthesis in hepatocytes. Journal of the Formosan Medical Association = Taiwan Yi Zhi. PMID 32284164 DOI: 10.1016/J.Jfma.2020.03.018 |
0.338 |
|
| 2020 |
Huang CF, Lai HC, Chen CY, Tseng KC, Kuo HT, Hung CH, Wang JH, Chen JJ, Lee PL, Chien RN, Yang CC, Lo GH, Tai CM, Lin CW, Kao JH, et al. Extrahepatic Malignancy Among Patients With Chronic Hepatitis C After Antiviral Therapy: A Real-World Nationwide Study on Taiwanese Chronic Hepatitis C Cohort (T-COACH). The American Journal of Gastroenterology. PMID 32221162 DOI: 10.14309/ajg.0000000000000606 |
0.404 |
|
| 2020 |
Nguyen MH, Wong G, Gane E, Kao JH, Dusheiko G. Hepatitis B Virus: Advances in Prevention, Diagnosis, and Therapy. Clinical Microbiology Reviews. 33. PMID 32102898 DOI: 10.1128/CMR.00046-19 |
0.427 |
|
| 2020 |
Tseng TC, Liu CJ, Chang CT, Su TH, Yang WT, Tsai CH, Chen CL, Yang HC, Liu CH, Chen PJ, Chen DS, Kao JH. HEV superinfection accelerates disease progression in patients with chronic HBV infection and increases mortality in those with cirrhosis. Journal of Hepatology. PMID 32006586 DOI: 10.1016/J.Jhep.2020.01.012 |
0.4 |
|
| 2020 |
Liu CH, Yang SS, Peng CY, Lin WT, Liu CJ, Su TH, Tseng TC, Chen PJ, Chen DS, Kao JH. Glecaprevir/pibrentasvir for patients with chronic hepatitis C virus infection and severe renal impairment. Journal of Viral Hepatitis. PMID 31981264 DOI: 10.1111/jvh.13265 |
0.397 |
|
| 2020 |
Wang CC, Tzeng IS, Su WC, Li CH, Lin HH, Yang CC, Kao JH. The association of vitamin D with hepatitis B virus replication: Bystander rather than offender. Journal of the Formosan Medical Association = Taiwan Yi Zhi. PMID 31932201 DOI: 10.1016/j.jfma.2019.12.004 |
0.323 |
|
| 2020 |
Su TH, Chen CL, Kao JH. Letter: hepatitis B virus infection and risk of multiple myeloma-a meta-analysis of cohort studies. Authors' reply. Alimentary Pharmacology & Therapeutics. 51: 310-311. PMID 31880017 DOI: 10.1111/apt.15607 |
0.335 |
|
| 2019 |
Liu CH, Lee MH, Lin JW, Liu CJ, Su TH, Tseng TC, Chen PJ, Chen DS, Kao JH. Evolution of eGFR in chronic HCV patients receiving sofosbuvir-based or sofosbuvir-free direct acting antivirals. Journal of Hepatology. PMID 31790766 DOI: 10.1016/j.jhep.2019.11.014 |
0.35 |
|
| 2019 |
Ogawa E, Toyoda H, Iio E, Jun DW, Huang CF, Enomoto M, Hsu YC, Haga H, Iwane S, Wong G, Lee DH, Tada T, Liu CH, Chuang WL, Hayashi J, ... Kao JH, et al. HCV Cure Rates are Reduced in Patients with Active but not Inactive Hepatocellular Carcinoma- A Practice Implication. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. PMID 31777940 DOI: 10.1093/cid/ciz1160 |
0.319 |
|
| 2019 |
Wang CC, Cheng PN, Kao JH. Systematic review: chronic viral hepatitis and metabolic derangement. Alimentary Pharmacology & Therapeutics. PMID 31746482 DOI: 10.1111/apt.15575 |
0.395 |
|
| 2019 |
Liu CH, Liu CJ, Hung CC, Hsieh SM, Su TH, Sun HY, Tseng TC, Chen PJ, Chen DS, Kao JH. Glecaprevir/pibrentasvir for patients with chronic hepatitis C virus infection: real-world effectiveness and safety in Taiwan. Liver International : Official Journal of the International Association For the Study of the Liver. PMID 31710759 DOI: 10.1111/liv.14295 |
0.379 |
|
| 2019 |
Hsu SJ, Enkhzaya S, Lin YY, Tseng TC, Khosbayar T, Tsai CH, Wang TS, Enkhtuya D, Ivshinkhorol D, Naranzul N, Jargalsaikhan B, Amarsanaa J, Baatarkhuu O, Kao JH. Resistance-associated substitution and ledipasvir/sofosbuvir therapy in Mongolian chronic hepatitis C patients. Journal of the Formosan Medical Association = Taiwan Yi Zhi. PMID 31672433 DOI: 10.1016/j.jfma.2019.10.003 |
0.39 |
|
| 2019 |
Hsu SJ, Yang SS, Kao JH. Risk of hepatocellular carcinoma development after hepatitis C virus eradicated by direct-acting antivirals: Fact or fiction? Journal of the Formosan Medical Association = Taiwan Yi Zhi. PMID 31627984 DOI: 10.1016/j.jfma.2019.09.006 |
0.375 |
|
| 2019 |
Su TH, Peng CY, Tseng TC, Yang HC, Liu CJ, Liu CH, Chen PJ, Chen DS, Kao JH. Serum Mac-2-binding protein glycosylation isomer at virological remission predicts hepatocellular carcinoma and death in chronic hepatitis B related cirrhosis. The Journal of Infectious Diseases. PMID 31574141 DOI: 10.1093/infdis/jiz496 |
0.368 |
|
| 2019 |
Yang HI, Yeh ML, Wong GL, Peng CY, Chen CH, Trinh HN, Cheung KS, Xie Q, Su TH, Kozuka R, Lee DH, Ogawa E, Zhao C, Ning HB, Huang R, ... ... Kao JH, et al. REAL-B (Real-world Effectiveness from the Asia Pacific Rim Liver Consortium for HBV) Risk Score for the Prediction of Hepatocellular Carcinoma in Chronic Hepatitis B Patients Treated with Oral Antiviral Therapy. The Journal of Infectious Diseases. PMID 31550363 DOI: 10.1093/Infdis/Jiz477 |
0.311 |
|
| 2019 |
Kanda T, Lau GKK, Wei L, Moriyama M, Yu ML, Chuang WL, Ibrahim A, Lesmana CRA, Sollano J, Kumar M, Jindal A, Sharma BC, Hamid SS, Kadir Dokmeci A, Mamun-Al-Mahtab, ... Kao JH, et al. APASL HCV guidelines of virus-eradicated patients by DAA on how to monitor HCC occurrence and HBV reactivation. Hepatology International. PMID 31541423 DOI: 10.1007/s12072-019-09988-7 |
0.374 |
|
| 2019 |
Kao JH, Berg T. Nucleos(t)ide analogues in patients with chronic hepatitis B: to stop or not to stop? Gut. PMID 31527067 DOI: 10.1136/gutjnl-2019-319648 |
0.393 |
|
| 2019 |
Su TH, Yang HC, Tseng TC, Chou SW, Lin CH, Liu CH, Liu CJ, Chen CL, Kao JH. Antiviral Therapy in Patients With Chronic Hepatitis C Is Associated With a Reduced Risk of Parkinsonism. Movement Disorders : Official Journal of the Movement Disorder Society. PMID 31505068 DOI: 10.1002/Mds.27848 |
0.365 |
|
| 2019 |
Tseng TC, Liu CJ, Hsu CY, Hong CM, Su TH, Yang WT, Chen CL, Yang HC, Huang YT, Fang-Tzu Kuo S, Liu CH, Chen PJ, Chen DS, Kao JH. High Level of Hepatitis B Core-related Antigen Associated With Increased Risk of Hepatocellular Carcinoma in Patients With Chronic HBV Infection of Intermediate Viral Load. Gastroenterology. PMID 31470004 DOI: 10.1053/J.Gastro.2019.08.028 |
0.382 |
|
| 2019 |
Huang CF, Iio E, Jun DW, Ogawa E, Toyoda H, Hsu YC, Haga H, Iwane S, Enomoto M, Lee DH, Wong G, Liu CH, Tada T, Chuang WL, Cheung R, ... Kao JH, et al. Direct-acting antivirals in East Asian hepatitis C patients: real-world experience from the REAL-C Consortium. Hepatology International. PMID 31463665 DOI: 10.1007/s12072-019-09974-z |
0.359 |
|
| 2019 |
Hsu SJ, Chiu MC, Fang YJ, Yang TH, Yu JJ, Chen CC, Kuo CC, Lee JY, Chen CH, Chen DS, Kao JH. Real-world effectiveness and safety of glecaprevir/pibrentasvir in Asian patients with chronic hepatitis C. Journal of the Formosan Medical Association = Taiwan Yi Zhi. PMID 31279502 DOI: 10.1016/j.jfma.2019.06.014 |
0.416 |
|
| 2019 |
Wei L, Pavlovic V, Bansal AT, Chen X, Foster GR, He H, Kao JH, Lampertico P, Liaw YF, Motoc A, Papatheodoridis GV, Piratvisuth T, Plesniak R, Wat C. Genetic variation in FCER1A predicts peginterferon alfa-2a-induced hepatitis B surface antigen clearance in East Asian patients with chronic hepatitis B. Journal of Viral Hepatitis. PMID 30972912 DOI: 10.1111/jvh.13107 |
0.3 |
|
| 2019 |
Huang CF, Hung CH, Cheng PN, Bair MJ, Huang YH, Kao JH, Hsu SJ, Lee PL, Chen JJ, Chien RN, Peng CY, Lin CY, Hsieh TY, Cheng CH, Dai CY, et al. An open-label, randomized, active control trial of 8 versus 12 weeks of elbasvir/grazoprevir for treatment-naïve chronic hepatitis C genotype 1b patients with mild fibrosis (EGALITE): Impact of baseline viral loads and NS5A resistance-associated substitution. The Journal of Infectious Diseases. PMID 30957170 DOI: 10.1093/infdis/jiz154 |
0.414 |
|
| 2019 |
Liu CH, Shih YL, Yang SS, Lin CL, Fang YJ, Cheng PN, Chen CY, Peng CY, Hsieh TY, Chiu YC, Su TH, Liu CJ, Yang HC, Chen PJ, Chen DS, Kao JH, et al. Paritaprevir/ritonavir, ombitasvir plus dasabuvir for East-Asian non-cirrhotic hepatitis C virus genotype 1b patients receiving hemodialysis. Journal of Gastroenterology and Hepatology. PMID 30931537 DOI: 10.1111/jgh.14672 |
0.61 |
|
| 2019 |
Hsu YC, Tseng CH, Kao JH. Quantification of Hepatitis B Core Antibody Helps Predict Clinical Relapse After Cessation of Nucleos(t)ide Analogues in Chronic Hepatitis B Patients: More Needs to Be Done. Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association. 17: 1000-1001. PMID 30902225 DOI: 10.1016/j.cgh.2018.09.002 |
0.418 |
|
| 2019 |
Pavlovic V, Yang L, Chan HL, Hou J, Janssen HL, Kao JH, Lampertico P, Peng CY, Piratvisuth T, Thompson AJ, Wedemeyer H, Wei L, Wat C. Peginterferon alfa-2a (40 kD) stopping rules in chronic hepatitis B: a systematic review and meta-analysis of individual participant data. Antiviral Therapy. PMID 30865588 DOI: 10.3851/IMP3304 |
0.304 |
|
| 2019 |
Chen SH, Lai HC, Chiang IP, Su WP, Lin CH, Kao JT, Chuang PH, Hsu WF, Wang HW, Chen HY, Huang GT, Peng CY. Performance of Acoustic Radiation Force Impulse Elastography for Staging Liver Fibrosis in Patients with Chronic Hepatitis C after Viral Eradication. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. PMID 30816416 DOI: 10.1093/cid/ciz161 |
0.328 |
|
| 2019 |
Wang CC, Kao JH. The role of hepatitis B surface antigen in nucleos(t)ide analogues cessation among Asian chronic hepatitis B patients: friend or foe? Hepatology (Baltimore, Md.). PMID 30703245 DOI: 10.1002/hep.30532 |
0.406 |
|
| 2019 |
Liu CH, Su TH, Liu CJ, Hong CM, Yang HC, Tseng TC, Chen PJ, Chen DS, Kao JH. Sofosbuvir-based direct acting antiviral therapies for patients with hepatitis C virus genotype 2 infection. Journal of Gastroenterology and Hepatology. PMID 30693965 DOI: 10.1111/Jgh.14615 |
0.394 |
|
| 2019 |
Su TH, Liu CJ, Tseng TC, Chou SW, Liu CH, Yang HC, Wu SJ, Chen PJ, Chen DS, Chen CL, Kao JH. Chronic hepatitis B is associated with an increased risk of B-cell non-Hodgkin's lymphoma and multiple myeloma. Alimentary Pharmacology & Therapeutics. PMID 30681172 DOI: 10.1111/Apt.15132 |
0.378 |
|
| 2018 |
Su TH, Liu CJ, Tseng TC, Chou SW, Liu CH, Yang HC, Wu SJ, Chen PJ, Chen DS, Chen CL, Kao JH. Early antiviral therapy reduces the risk of lymphoma in patients with chronic hepatitis C infection. Alimentary Pharmacology & Therapeutics. PMID 30592071 DOI: 10.1111/Apt.15101 |
0.367 |
|
| 2018 |
Liu CH, Liu CJ, Su TH, Yang HC, Hong CM, Tseng TC, Chen PJ, Chen DS, Kao JH. Real-world effectiveness and safety of sofosbuvir and ledipasvir with or without ribavirin for patients with hepatitis C virus genotype 1 infection in Taiwan. Plos One. 13: e0209299. PMID 30576344 DOI: 10.1371/Journal.Pone.0209299 |
0.368 |
|
| 2018 |
Kanda T, Lau GKK, Wei L, Moriyama M, Yu ML, Chuang WL, Ibrahim A, Lesmana CRA, Sollano J, Kumar M, Jindal A, Sharma BC, Hamid SS, Dokmeci AK, Mamun-Al-Mahtab, ... Kao JH, et al. APASL clinical practice recommendation: how to treat HCV-infected patients with renal impairment? Hepatology International. PMID 30539517 DOI: 10.1007/s12072-018-9915-5 |
0.308 |
|
| 2018 |
Yu ML, Hung CH, Huang YH, Peng CY, Lin CY, Cheng PN, Chien RN, Hsu SJ, Liu CH, Huang CF, Su CW, Huang JF, Liu CJ, Kao JH, Chuang WL, et al. Efficacy and safety of 12 weeks of daclatasvir, asunaprevir plus ribavirin for HCV genotype-1b infection without NS5A resistance-associated substitutions. Journal of the Formosan Medical Association = Taiwan Yi Zhi. PMID 30527566 DOI: 10.1016/j.jfma.2018.11.007 |
0.361 |
|
| 2018 |
Chien RN, Kao JH, Peng CY, Chen CH, Liu CJ, Huang YH, Hu TH, Yang HI, Lu SN, Ni YH, Chuang WL, Lee CM, Wu JC, Chen PJ, Liaw YF. Taiwan consensus statement on the management of chronic hepatitis B. Journal of the Formosan Medical Association = Taiwan Yi Zhi. PMID 30527436 DOI: 10.1016/j.jfma.2018.11.008 |
0.396 |
|
| 2018 |
Liu CH, Yu ML, Peng CY, Hsieh TY, Huang YH, Su WW, Cheng PN, Lin CL, Lo CC, Chen CY, Chen JJ, Ma Q, Brooks-Rooney C, Kao JH. Real-world anti-viral treatment decisions among chronic hepatitis C patients in Taiwan: The INITIATE study. Journal of the Formosan Medical Association = Taiwan Yi Zhi. PMID 30448077 DOI: 10.1016/j.jfma.2018.10.020 |
0.569 |
|
| 2018 |
Liu CH, Yu ML, Peng CY, Hsieh TY, Huang YH, Su WW, Cheng PN, Lin CL, Lo CC, Chen CY, Chen JJ, Ma Q, Brooks-Rooney C, Kao JH. Comorbidities, concomitant medications and potential drug-drug interactions with interferon-free direct-acting antiviral agents in hepatitis C patients in Taiwan. Alimentary Pharmacology & Therapeutics. PMID 30362139 DOI: 10.1111/apt.15011 |
0.478 |
|
| 2018 |
Yeo YH, Ho HJ, Yang HI, Tseng TC, Hosaka T, Trinh HN, Kwak MS, Park YM, Fung JYY, Buti M, Rodriguez M, Treeprasertsuk S, Preda CM, Ungtrakul T, Charatcharoenwitthaya P, ... Kao JH, et al. Factors Associated with Rates of HBsAg Seroclearance in Adults with Chronic HBV Infection: A systematic review and meta-analysis. Gastroenterology. PMID 30342034 DOI: 10.1053/J.Gastro.2018.10.027 |
0.366 |
|
| 2018 |
Hong CM, Liu CH, Su TH, Yang HC, Chen PJ, Chen YW, Kao JH, Liu CJ. Real-world effectiveness of direct-acting antiviral agents for chronic hepatitis C in Taiwan: Real-world data. Journal of Microbiology, Immunology, and Infection = Wei Mian Yu Gan Ran Za Zhi. PMID 30316726 DOI: 10.1016/J.Jmii.2018.09.005 |
0.348 |
|
| 2018 |
Yang HC, Kao JH. Quantification of HBV core antibodies may help revisit infectious occult hepatitis B virus. Gut. PMID 30301771 DOI: 10.1136/Gutjnl-2018-317385 |
0.354 |
|
| 2018 |
Tsai SM, Kao JT, Tsai YF. Illness trajectory of initial infection for patients with hepatitis C: A qualitative study. Nursing & Health Sciences. PMID 30251452 DOI: 10.1111/nhs.12568 |
0.337 |
|
| 2018 |
Liu CH, Huang YJ, Yang SS, Chang CH, Yang SS, Sun HY, Liu CJ, Liu WC, Su TH, Yang HC, Hong CM, Tseng TC, Chen PJ, Chen DS, Hung CC, ... Kao JH, et al. Generic sofosbuvir-based interferon-free direct acting antiviral agents for patients with chronic hepatitis C virus infection: a real-world multicenter observational study. Scientific Reports. 8: 13699. PMID 30209349 DOI: 10.1038/S41598-018-32060-7 |
0.36 |
|
| 2018 |
Kao JH. Hepatitis B: From control to cure. Journal of the Formosan Medical Association = Taiwan Yi Zhi. PMID 30201191 DOI: 10.1016/j.jfma.2018.08.020 |
0.384 |
|
| 2018 |
Liu CJ, Tseng TC, Yang WT, Su TH, Yang HC, Liu CH, Chen PJ, Chen DS, Kao JH. Profile and Value of FIB-4 in Patients with Dual Chronic Hepatitis C and B. Journal of Gastroenterology and Hepatology. PMID 30151861 DOI: 10.1111/Jgh.14455 |
0.469 |
|
| 2018 |
Lin CL, Kao JH. Review article: the prevention of hepatitis B-related hepatocellular carcinoma. Alimentary Pharmacology & Therapeutics. PMID 29722445 DOI: 10.1111/apt.14683 |
0.341 |
|
| 2018 |
Reau N, Kwo PY, Rhee S, Brown RS, Agarwal K, Angus P, Gane E, Kao JH, Mantry PS, Mutimer D, Reddy KR, Tran TT, Hu YB, Gulati A, Krishnan P, et al. Glecaprevir/Pibrentasvir Treatment in Liver or Kidney Transplant Patients With Hepatitis C Virus Infection. Hepatology (Baltimore, Md.). PMID 29672891 DOI: 10.1002/Hep.30046 |
0.35 |
|
| 2018 |
Liu CH, Sun HY, Liu CJ, Sheng WH, Hsieh SM, Lo YC, Liu WC, Su TH, Yang HC, Hong CM, Tseng TC, Chen PJ, Chen DS, Hung CC, Kao JH. Generic velpatasvir plus sofosbuvir for hepatitis C virus infection in patients with or without human immunodeficiency virus coinfection. Alimentary Pharmacology & Therapeutics. PMID 29665069 DOI: 10.1111/apt.14647 |
0.34 |
|
| 2018 |
Lin CL, Kao JH. Prevention of mother-to-child transmission: the key of hepatitis B virus elimination. Hepatology International. PMID 29619622 DOI: 10.1007/s12072-018-9863-0 |
0.562 |
|
| 2018 |
Tseng TC, Liu CJ, Su TH, Yang WT, Chen CL, Yang HC, Kuo SF, Liu CH, Chen PJ, Chen DS, Kao JH. Fibrosis-4 index predicts cirrhosis risk and liver-related mortality in 2075 patients with chronic HBV infection. Alimentary Pharmacology & Therapeutics. PMID 29601647 DOI: 10.1111/apt.14619 |
0.453 |
|
| 2018 |
Su TH, Liao CH, Liu CH, Huang KW, Tseng TC, Yang HC, Liu CJ, Chen PJ, Chen DS, Kao JH. Acoustic Radiation Force Impulse US Imaging: Liver Stiffness in Patients with Chronic Hepatitis B with and without Antiviral Therapy. Radiology. 171116. PMID 29584594 DOI: 10.1148/Radiol.2018171116 |
0.337 |
|
| 2018 |
Lin HH, Tseng TC, Kao JH. Large and middle hepatitis B surface antigen: the lower the better? Gut. PMID 29514859 DOI: 10.1136/gutjnl-2018-316030 |
0.334 |
|
| 2018 |
Hsu CW, Su WW, Lee CM, Peng CY, Chuang WL, Kao JH, Chu HC, Huang YH, Chien RN, Liaw YF. Phase IV randomized clinical study: Peginterferon alfa-2a with adefovir or entecavir pre-therapy for HBeAg-positive chronic hepatitis B. Journal of the Formosan Medical Association = Taiwan Yi Zhi. PMID 29456079 DOI: 10.1016/j.jfma.2017.12.007 |
0.392 |
|
| 2018 |
Rivino L, Le Bert N, Gill US, Kunasegaran K, Cheng Y, Tan DZ, Becht E, Hansi NK, Foster GR, Su TH, Tseng TC, Lim SG, Kao JH, Newell EW, Kennedy PT, et al. Hepatitis B virus-specific T cells associate with viral control upon nucleos(t)ide-analogue therapy discontinuation. The Journal of Clinical Investigation. PMID 29309050 DOI: 10.1172/JCI92812 |
0.376 |
|
| 2018 |
Chen SH, Lai HC, Chiang IP, Su WP, Lin CH, Kao JT, Chuang PH, Hsu WF, Wang HW, Chen HY, Huang GT, Peng CY. Changes in liver stiffness measurement using acoustic radiation force impulse elastography after antiviral therapy in patients with chronic hepatitis C. Plos One. 13: e0190455. PMID 29293628 DOI: 10.1371/journal.pone.0190455 |
0.33 |
|
| 2017 |
Tseng CH, Hsu YC, Chang CY, Tseng TC, Wu MS, Lin JT, Kao JH. Quantification of serum hepatitis B core antibody to predict off-entecavir relapse in patients with chronic hepatitis B. Journal of the Formosan Medical Association = Taiwan Yi Zhi. PMID 29249417 DOI: 10.1016/j.jfma.2017.11.012 |
0.394 |
|
| 2017 |
Chien NH, Huang YT, Wu CY, Chang CY, Wu MS, Kao JH, Mo LR, Tai CM, Lin CW, Yang TH, Lin JT, Hsu YC. Time-varying serum gradient of hepatitis B surface antigen predicts risk of relapses after off-NA therapy. Bmc Gastroenterology. 17: 154. PMID 29221441 DOI: 10.1186/s12876-017-0697-3 |
0.376 |
|
| 2017 |
Su TH, Kao JH. Unmet Needs in Clinical and Basic Hepatitis B Virus Research. The Journal of Infectious Diseases. 216: S750-S756. PMID 29156048 DOI: 10.1093/infdis/jix382 |
0.426 |
|
| 2017 |
Liu CJ, Kao JH. NOhep: Toward Global Control of Hepatitis B Virus Infection-An Introduction. The Journal of Infectious Diseases. 216: S749. PMID 29156045 DOI: 10.1093/infdis/jix313 |
0.362 |
|
| 2017 |
Maaroufi A, Vince A, Himatt SM, Mohamed R, Fung J, Opare-Sem O, Workneh A, Njouom R, Al Ghazzawi I, Abdulla M, Kaliaskarova KS, Owusu-Ofori S, Abdelmageed MK, Adda D, Akin O, ... ... Kao JH, et al. Historical epidemiology of hepatitis C virus in select countries-volume 4. Journal of Viral Hepatitis. 24: 8-24. PMID 29105285 DOI: 10.1111/jvh.12762 |
0.339 |
|
| 2017 |
Liu CH, Chen YS, Wang SS, Liu CJ, Su TH, Yang HC, Hong CM, Chen PJ, Chen DS, Kao JH. Sofosbuvir-based interferon-free direct acting antiviral regimens for heart transplant recipients with chronic hepatitis C virus infection. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. PMID 29020359 DOI: 10.1093/Cid/Cix787 |
0.343 |
|
| 2017 |
Papatheodoridis GV, Manolakopoulos S, Su TH, Siakavellas S, Liu CJ, Kourikou A, Yang HC, Kao JH. Significance of definitions of relapse after discontinuation of oral antivirals in HBeAg-negative chronic hepatitis B. Hepatology (Baltimore, Md.). PMID 28859219 DOI: 10.1002/Hep.29497 |
0.345 |
|
| 2017 |
Tseng TC, Liu CJ, Su TH, Yang WT, Chen CL, Yang HC, Wang CC, Kuo SF, Liu CH, Chen PJ, Chen DS, Kao JH. Fibrosis-4 Index Helps Identify HBV Carriers With the Lowest Risk of Hepatocellular Carcinoma. The American Journal of Gastroenterology. PMID 28853728 DOI: 10.1038/Ajg.2017.254 |
0.339 |
|
| 2017 |
Lin CL, Kao JH. Natural history of acute and chronic hepatitis B: The role of HBV genotypes and mutants. Best Practice & Research. Clinical Gastroenterology. 31: 249-255. PMID 28774406 DOI: 10.1016/j.bpg.2017.04.010 |
0.622 |
|
| 2017 |
Liu CH, Liu CJ, Su TH, Yang HC, Hong CM, Tseng TC, Chen PJ, Chen DS, Kao JH. Real-world effectiveness and safety of paritaprevir/ritonavir, ombitasvir, and dasabuvir with or without ribavirin for patients with chronic hepatitis C virus genotype 1b infection in Taiwan. Journal of Gastroenterology and Hepatology. PMID 28762541 DOI: 10.1111/Jgh.13912 |
0.44 |
|
| 2017 |
Hsieh MH, Yeh ML, Su TH, Liu TW, Huang CF, Huang CI, Wang SC, Huang JF, Dai CY, Kao JH, Chuang WL, Chen PJ, Liu CJ, Yu ML. Boceprevir-based triple therapy to rescue HCV genotype 1/HBV dually infected patients refractory to peginterferon plus ribavirin combination therapy in Taiwan. Journal of the Formosan Medical Association = Taiwan Yi Zhi. PMID 28694000 DOI: 10.1016/j.jfma.2017.06.007 |
0.397 |
|
| 2017 |
Lee MH, Huang CF, Lai HC, Lin CY, Dai CY, Liu CJ, Wang JH, Huang JF, Su WP, Yang HC, Kee KM, Yeh ML, Chuang PH, Hsu SJ, Huang CI, Kao JT, ... Kao JH, et al. Clinical Efficacy and Post-Treatment Seromarkers Associated with the Risk of Hepatocellular Carcinoma among Chronic Hepatitis C Patients. Scientific Reports. 7: 3718. PMID 28623331 DOI: 10.1038/S41598-017-02313-Y |
0.319 |
|
| 2017 |
Wang CC, Kao JH. Letter: the influence of direct acting agents for hepatitis C, on hepatitis B reactivation. Alimentary Pharmacology & Therapeutics. 46: 208. PMID 28621067 DOI: 10.1111/apt.14116 |
0.424 |
|
| 2017 |
Liu CH, Liu CJ, Hong CM, Su TH, Yang HC, Chen KM, Huang YP, Yeh YM, Tien HL, Liu YC, Kao JH, Chen DS, Chen PJ. A noninvasive diagnosis of hepatic fibrosis by BioFibroScore® in chronic hepatitis C patients. Journal of Gastroenterology and Hepatology. PMID 28548299 DOI: 10.1111/Jgh.13834 |
0.444 |
|
| 2017 |
Wang CC, Kao JH. Hepatitis B virus infection and decreased risk of nonalcoholic fatty liver disease: A cohort study. Hepatology (Baltimore, Md.). PMID 28480982 DOI: 10.1002/hep.29252 |
0.379 |
|
| 2017 |
Liu CH, Liu CJ, Su TH, Fang YJ, Yang HC, Chen PJ, Chen DS, Kao JH. Hepatitis B Virus Reactivation in Patients Receiving Interferon-Free Direct-Acting Antiviral Agents for Chronic Hepatitis C Virus Infection. Open Forum Infectious Diseases. 4: ofx028. PMID 28480296 DOI: 10.1093/Ofid/Ofx028 |
0.454 |
|
| 2017 |
Tseng TC, Kao JH. Elimination of Hepatitis B: Is It a Mission Possible? Bmc Medicine. 15: 53. PMID 28292309 DOI: 10.1186/s12916-017-0820-x |
0.426 |
|
| 2017 |
Hsu YC, Mo LR, Chang CY, Wu MS, Yang TH, Kao JH, Chen CC, Tseng CH, Tai CM, Lin CW, Wu CY, Lin JT. Serum viral load at the virological relapse predicts subsequent clinical flares in chronic hepatitis B patients off entecavir therapy. Journal of Gastroenterology and Hepatology. PMID 28122151 DOI: 10.1111/jgh.13728 |
0.412 |
|
| 2017 |
Nien HC, Hsu SJ, Su TH, Yang PJ, Sheu JC, Wang JT, Chow LP, Chen CL, Kao JH, Yang WS. High Serum Lipopolysaccharide-Binding Protein Level in Chronic Hepatitis C Viral Infection Is Reduced by Anti-Viral Treatments. Plos One. 12: e0170028. PMID 28107471 DOI: 10.1371/journal.pone.0170028 |
0.343 |
|
| 2017 |
Liu CH, Chen YS, Wang SS, Kao JH. Treatment of de novo hepatitis C virus-related fibrosing cholestatic hepatitis after orthotopic heart transplantation by ledipasvir and sofosbuvir. Journal of the Formosan Medical Association = Taiwan Yi Zhi. PMID 28089092 DOI: 10.1016/j.jfma.2016.12.005 |
0.352 |
|
| 2017 |
Su TH, Kao JH. Response to Four-year entecavir therapy reduces hepatocellular carcinoma, cirrhotic events and mortality in chronic hepatitis B patients. Liver International : Official Journal of the International Association For the Study of the Liver. 37: 310-311. PMID 28070982 DOI: 10.1111/liv.13315 |
0.353 |
|
| 2017 |
Lin CL, Kao JH. Hepatitis B reactivation in patients receiving immunosuppressive therapy: a hidden menace. Hepatology International. PMID 28058576 DOI: 10.1007/s12072-016-9782-x |
0.589 |
|
| 2017 |
Kao CN, Su TH, Kao JH. Letter: HBsAg kinetics-guided interferon therapy for chronic hepatitis D. Alimentary Pharmacology & Therapeutics. 45: 480-481. PMID 28043091 DOI: 10.1111/apt.13872 |
0.325 |
|
| 2016 |
Lin CL, Kao JH. New perspectives of biomarkers for the management of chronic hepatitis B. Clinical and Molecular Hepatology. 22: 423-431. PMID 28081591 DOI: 10.3350/cmh.2016.0069 |
0.621 |
|
| 2016 |
Chen HY, Su TH, Tseng TC, Yang WT, Chen TC, Chen PJ, Chen DS, Kao JH, Liu CJ. Impact of occult hepatitis B on the clinical outcomes of patients with chronic hepatitis C virus infection: A 10-year follow-up. Journal of the Formosan Medical Association = Taiwan Yi Zhi. PMID 28012674 DOI: 10.1016/j.jfma.2016.11.002 |
0.488 |
|
| 2016 |
Kao JH, Ahn SH, Chien RN, Cho M, Chuang WL, Jeong SH, Liu CH, Paik SW. Urgency to treat patients with chronic hepatitis C in Asia. Journal of Gastroenterology and Hepatology. PMID 28005275 DOI: 10.1111/jgh.13709 |
0.377 |
|
| 2016 |
Wei L, Kao JH. Benefits of long-term therapy with nucleos(t)ide analogues in treatment-naïve patients with chronic hepatitis B. Current Medical Research and Opinion. 1-32. PMID 27882776 DOI: 10.1080/03007995.2016.1264932 |
0.381 |
|
| 2016 |
Mah YH, Liu CH, Chen CL, Tseng TC, Liu CJ, Chen PJ, Chen DS, Kao JH. Prevalence and clinical implications of IL28B genotypes in Taiwanese patients with chronic hepatitis C. Journal of the Formosan Medical Association = Taiwan Yi Zhi. PMID 27751759 DOI: 10.1016/j.jfma.2016.07.013 |
0.383 |
|
| 2016 |
Su TH, Hu TH, Chen CY, Huang YH, Chuang WL, Lin CC, Wang CC, Su WW, Chen MY, Peng CY, Chien RN, Huang YW, Wang HY, Lin CL, Yang SS, ... Kao JH, et al. Four-Year Entecavir Therapy Reduces Hepatocellular Carcinoma, Cirrhotic Events, and Mortality in Chronic Hepatitis B Patients. Liver International : Official Journal of the International Association For the Study of the Liver. PMID 27634134 DOI: 10.1111/liv.13253 |
0.565 |
|
| 2016 |
Wu HL, Hsiao TH, Chen PJ, Wong SH, Kao JH, Chen DS, Lu JY, Lu TP, Chen Y, Chuang EY, Tu HC, Liu CJ. Liver Gene Expression Profiles Correlate with Virus Infection and Response to Interferon Therapy in Chronic Hepatitis B Patients. Scientific Reports. 6: 31349. PMID 27546197 DOI: 10.1038/srep31349 |
0.381 |
|
| 2016 |
Kao JH, Asselah T, Dou XG, Hamed K. Telbivudine therapy for chronic hepatitis B: a journey to identify super-responders and to optimize treatment using the roadmap model. Journal of Gastroenterology and Hepatology. PMID 27515408 DOI: 10.1111/jgh.13512 |
0.389 |
|
| 2016 |
Sulkowski MS, Chuang WL, Kao JH, Yang JC, Gao B, Brainard DM, Han KH, Gane E. No Evidence of Reactivation of Hepatitis B Virus Among Patients Treated with Ledipasvir-Sofosbuvir for Hepatitis C Virus Infection. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. PMID 27486112 DOI: 10.1093/cid/ciw507 |
0.464 |
|
| 2016 |
Tsai SM, Kao JT, Tsai YF. How hepatitis C patients manage the treatment process of pegylated interferon and ribavirin therapy: a qualitative study. Bmc Health Services Research. 16: 247. PMID 27402141 DOI: 10.1186/s12913-016-1503-6 |
0.397 |
|
| 2016 |
Flisiak R, Kawazoe S, Znoyko O, Assy N, Gadano A, Kao JH, Lee KS, Zwirtes R, Portsmouth S, Dong Y, Xu D, Kumada H, Srinivasan S. Peginterferon Lambda-1a/Ribavirin with Daclatasvir or Peginterferon Alfa-2a/Ribavirin with Telaprevir for Chronic Hepatitis C Genotype 1b. Journal of Interferon & Cytokine Research : the Official Journal of the International Society For Interferon and Cytokine Research. PMID 27327078 DOI: 10.1089/jir.2015.0173 |
0.378 |
|
| 2016 |
Lin CL, Kao JH. Review article: novel therapies for hepatitis B virus cure - advances and perspectives. Alimentary Pharmacology & Therapeutics. PMID 27302653 DOI: 10.1111/apt.13694 |
0.442 |
|
| 2016 |
Omata M, Kanda T, Wei L, Yu ML, Chuang WL, Ibrahim A, Lesmana CR, Sollano J, Kumar M, Jindal A, Sharma BC, Hamid SS, Dokmeci AK, Al-Mahtab M, McCaughan GW, ... Kao JH, et al. APASL consensus statements and recommendations for hepatitis C prevention, epidemiology, and laboratory testing. Hepatology International. PMID 27229718 DOI: 10.1007/s12072-016-9736-3 |
0.327 |
|
| 2016 |
Omata M, Kanda T, Wei L, Yu ML, Chuang WL, Ibrahim A, Lesmana CR, Sollano J, Kumar M, Jindal A, Sharma BC, Hamid SS, Dokmeci AK, Mamun-Al-Mahtab, McCaughan GW, ... Kao JH, et al. APASL consensus statements and recommendation on treatment of hepatitis C. Hepatology International. PMID 27130427 DOI: 10.1007/s12072-016-9717-6 |
0.339 |
|
| 2016 |
Wang CC, Tseng KC, Hsieh TY, Tseng TC, Lin HH, Kao JH. Assessing the Durability of Entecavir-Treated Hepatitis B Using Quantitative HBsAg. The American Journal of Gastroenterology. PMID 27045923 DOI: 10.1038/ajg.2016.109 |
0.431 |
|
| 2016 |
Hsu YC, Mo LR, Chang CY, Wu MS, Kao JH, Wang WL, Yang TH, Wang CS, Chiang MF, Chen CC, Fang YJ, Hung HW, Wu CY, Lin JT. Association Between Serum Level of Hepatitis B Surface Antigen at End of Entecavir Therapy and Risk of Relapse in e Antigen-negative Patients. Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association. PMID 27018299 DOI: 10.1016/j.cgh.2016.03.024 |
0.317 |
|
| 2016 |
Kao JH, Lee YJ, Heo J, Ahn SH, Lim YS, Peng CY, Chang TT, Torbeyns A, Hughes E, Bhore R, Noviello S. All-oral daclatasvir plus asunaprevir for chronic HCV genotype 1b infection: a sub-analysis in Asian patients from the HALLMARK DUAL study. Liver International : Official Journal of the International Association For the Study of the Liver. PMID 27009831 DOI: 10.1111/liv.13128 |
0.366 |
|
| 2016 |
Kao JH, Tung SY, Lee Y, Thongsawat S, Tanwandee T, Sheen IS, Wu JJ, Li H, Brennan BJ, Zhou J, Le Pogam S, Najera I, Thommes JA, Hill G. Ritonavir-boosted danoprevir plus peginterferon alfa-2a and ribavirin in Asian chronic hepatitis C patients with or without cirrhosis. Journal of Gastroenterology and Hepatology. PMID 26992248 DOI: 10.1111/jgh.13374 |
0.343 |
|
| 2016 |
Yang WT, Wu LW, Tseng TC, Chen CL, Yang HC, Su TH, Wang CC, Kuo SF, Liu CH, Chen PJ, Chen DS, Liu CJ, Kao JH. Hepatitis B Surface Antigen Loss and Hepatocellular Carcinoma Development in Patients With Dual Hepatitis B and C Infection. Medicine. 95: e2995. PMID 26962809 DOI: 10.1097/Md.0000000000002995 |
0.418 |
|
| 2016 |
Yang HC, Kao JH. Looking into the crystal ball: biomarkers for outcomes of HBV infection. Hepatology International. PMID 26732689 DOI: 10.1007/S12072-015-9698-X |
0.375 |
|
| 2015 |
Kao JH. Hepatitis B vaccination and prevention of hepatocellular carcinoma. Best Practice & Research. Clinical Gastroenterology. 29: 907-917. PMID 26651252 DOI: 10.1016/j.bpg.2015.09.011 |
0.371 |
|
| 2015 |
Yang HI, Tseng TC, Liu J, Lee MH, Liu CJ, Su TH, Batrla-Utermann R, Chan HL, Kao JH, Chen CJ. 'Incorporating Serum Level of Hepatitis B Surface Antigen or Omitting Level of HBV DNA Does not Affect Calculation of Risk for Hepatocellular Carcinoma in Patients Without Cirrhosis'. Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association. PMID 26598229 DOI: 10.1016/j.cgh.2015.10.033 |
0.393 |
|
| 2015 |
Sarin SK, Kumar M, Lau GK, Abbas Z, Chan HL, Chen CJ, Chen DS, Chen HL, Chen PJ, Chien RN, Dokmeci AK, Gane E, Hou JL, Jafri W, Jia J, ... Kao JH, et al. Asian-Pacific clinical practice guidelines on the management of hepatitis B: a 2015 update. Hepatology International. PMID 26563120 DOI: 10.1007/S12072-015-9675-4 |
0.343 |
|
| 2015 |
Yang SS, Kao JH. Daclatasvir-containing all-oral regimens for the treatment of hepatitis C virus infection. Hepatology International. PMID 26542068 DOI: 10.1007/s12072-015-9668-3 |
0.386 |
|
| 2015 |
Wang CC, Lin CL, Hsieh TY, Tseng KC, Peng CY, Su TH, Yang SS, Hsu YC, Chen TM, Kao JH. Efficacy and resistance to telbivudine treatment in chronic hepatitis B patients with favorable predictors: a multicenter study in Taiwan. Hepatology International. PMID 26399763 DOI: 10.1007/s12072-015-9662-9 |
0.588 |
|
| 2015 |
Wang CC, Liu CH, Lin CL, Wang PC, Tseng TC, Lin HH, Kao JH. Fibrosis index based on four factors better predicts advanced fibrosis or cirrhosis than aspartate aminotransferase/platelet ratio index in chronic hepatitis C patients. Journal of the Formosan Medical Association = Taiwan Yi Zhi. PMID 26279173 DOI: 10.1016/j.jfma.2015.07.004 |
0.585 |
|
| 2015 |
Kao JH. Hepatitis C virus infection in Taiwan: Past, present, and future. Journal of the Formosan Medical Association = Taiwan Yi Zhi. PMID 26228687 DOI: 10.1016/j.jfma.2015.06.012 |
0.328 |
|
| 2015 |
Lin CL, Kao JH. Can noninvasive biomarkers replace liver biopsy for chronic hepatitis B? Hepatology (Baltimore, Md.). PMID 25914237 DOI: 10.1002/hep.27865 |
0.593 |
|
| 2015 |
Tseng TC, Liu CJ, Chen CL, Yang WT, Yang HC, Su TH, Wang CC, Kuo SF, Liu CH, Chen PJ, Chen DS, Kao JH. Higher lifetime chance of spontaneous surface antigen loss in hepatitis B carriers with genotype C infection. Alimentary Pharmacology & Therapeutics. 41: 949-60. PMID 25809540 DOI: 10.1111/apt.13170 |
0.41 |
|
| 2015 |
Liu CH, Liang CC, Liu CJ, Lin CL, Su TH, Yang HC, Chen PJ, Chen DS, Kao JH. Comparison of Abbott RealTime HCV Genotype II with Versant line probe assay 2.0 for hepatitis C virus genotyping. Journal of Clinical Microbiology. 53: 1754-7. PMID 25740780 DOI: 10.1128/Jcm.03548-14 |
0.545 |
|
| 2015 |
Zeisel MB, Lucifora J, Mason WS, Sureau C, Beck J, Levrero M, Kann M, Knolle PA, Benkirane M, Durantel D, Michel ML, Autran B, Cosset FL, Strick-Marchand H, Trépo C, Kao JH, et al. Towards an HBV cure: state-of-the-art and unresolved questions-report of the ANRS workshop on HBV cure. Gut. 64: 1314-26. PMID 25670809 DOI: 10.1136/gutjnl-2014-308943 |
0.359 |
|
| 2015 |
Song LW, Liu PG, Liu CJ, Zhang TY, Cheng XD, Wu HL, Yang HC, Hao XK, Yuan Q, Zhang J, Kao JH, Chen DS, Chen PJ, Xia NS. Quantitative hepatitis B core antibody levels in the natural history of hepatitis B virus infection. Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases. 21: 197-203. PMID 25658546 DOI: 10.1016/j.cmi.2014.10.002 |
0.389 |
|
| 2015 |
Lin YY, Liu C, Chien WH, Wu LL, Tao Y, Wu D, Lu X, Hsieh CH, Chen PJ, Wang HY, Kao JH, Chen DS. New insights into the evolutionary rate of hepatitis B virus at different biological scales. Journal of Virology. 89: 3512-22. PMID 25589664 DOI: 10.1128/JVI.03131-14 |
0.309 |
|
| 2015 |
Liu J, Tseng TC, Yang HI, Lee MH, Batrla-Utermann R, Jen CL, Lu SN, Wang LY, You SL, Chen PJ, Chen CJ, Kao JH. Predicting Hepatitis B Virus (HBV) Surface Antigen Seroclearance in HBV e Antigen-Negative Patients With Chronic Hepatitis B: External Validation of a Scoring System. The Journal of Infectious Diseases. 211: 1566-73. PMID 25430663 DOI: 10.1093/infdis/jiu659 |
0.463 |
|
| 2015 |
Tseng TC, Kao JH. Treating Immune-tolerant Hepatitis B. Journal of Viral Hepatitis. 22: 77-84. PMID 25424771 DOI: 10.1111/jvh.12370 |
0.359 |
|
| 2015 |
Peng CY, Hsieh TC, Hsieh TY, Tseng KC, Lin CL, Su TH, Tseng TC, Lin HH, Wang CC, Kao JH. HBV-DNA level at 6 months of entecavir treatment predicts HBeAg loss in HBeAg-positive chronic hepatitis B patients. Journal of the Formosan Medical Association = Taiwan Yi Zhi. 114: 308-13. PMID 24315616 DOI: 10.1016/j.jfma.2013.10.023 |
0.605 |
|
| 2014 |
Hsu CS, Hsu SJ, Lin HH, Tseng TC, Wang CC, Chen DS, Kao JH. A pilot study of add-on oral hypoglycemic agents in treatment-naïve genotype-1 chronic hepatitis C patients receiving peginterferon alfa-2b plus ribavirin. Journal of the Formosan Medical Association = Taiwan Yi Zhi. 113: 716-21. PMID 24974131 DOI: 10.1016/j.jfma.2014.05.007 |
0.367 |
|
| 2014 |
Wang CC, Hsieh TC, Tseng TC, Wang PC, Hsu CS, Lin HH, Wang LY, Kao JH. Factors affecting the diagnostic accuracy of ultrasonography in assessing the severity of hepatic steatosis. Journal of the Formosan Medical Association = Taiwan Yi Zhi. 113: 249-54. PMID 24685301 DOI: 10.1016/j.jfma.2012.07.004 |
0.315 |
|
| 2014 |
Kao JH. HBeAg-positive chronic hepatitis B: why do I treat my patients with pegylated interferon? Liver International : Official Journal of the International Association For the Study of the Liver. 34: 112-9. PMID 24373087 DOI: 10.1111/liv.12400 |
0.427 |
|
| 2013 |
Hsu CS, Kao JH, Chao YC, Lin HH, Fan YC, Huang CJ, Tsai PS. Interferon-based therapy reduces risk of stroke in chronic hepatitis C patients: a population-based cohort study in Taiwan. Alimentary Pharmacology & Therapeutics. 38: 415-23. PMID 23802888 DOI: 10.1111/apt.12391 |
0.35 |
|
| 2013 |
Liu CJ, Kao JH. Treatment options for dual HCV/HBV coinfection Emerging Therapeutic Options For Hepatitis C. 73-84. DOI: 10.2217/EBO.12.276 |
0.476 |
|
| 2012 |
Hsu CS, Liu CH, Wang CC, Tseng TC, Liu CJ, Chen CL, Chen PJ, Chen DS, Kao JH. Impact of hepatitis B virus infection on metabolic profiles and modifying factors. Journal of Viral Hepatitis. 19: e48-57. PMID 22239526 DOI: 10.1111/j.1365-2893.2011.01535.x |
0.341 |
|
| 2011 |
Kao JH. Molecular epidemiology of hepatitis B virus. The Korean Journal of Internal Medicine. 26: 255-61. PMID 22016585 DOI: 10.3904/kjim.2011.26.3.255 |
0.488 |
|
| 2011 |
Liu CJ, Cheng HR, Chen CL, Chen TC, Tseng TC, Wang ZL, Chen PJ, Liu CH, Chen DS, Kao JH. Effects of hepatitis B virus precore and basal core promoter mutations on the expression of viral antigens: genotype B vs C. Journal of Viral Hepatitis. 18: e482-90. PMID 21914067 DOI: 10.1111/j.1365-2893.2011.01480.x |
0.364 |
|
| 2011 |
Hsu CS, Kao JH. Hepatitis C virus and lipid profiles: more questions than answers? Hepatology International. 5: 865-7. PMID 21800144 DOI: 10.1007/s12072-011-9298-3 |
0.311 |
|
| 2011 |
Su TH, Chen PJ, Chen TC, Cheng HR, Li L, Lin KS, Kao JH, Chen DS, Liu CJ. The clinical significance of occult hepatitis B transfusion in Taiwan--a look-back study. Transfusion Medicine (Oxford, England). 21: 33-41. PMID 20726954 DOI: 10.1111/j.1365-3148.2010.01036.x |
0.41 |
|
| 2011 |
Kao JH. Control by Vaccination: Asian and Taiwan Experience Clinical Dilemmas in Primary Liver Cancer. 18-23. DOI: 10.1002/9781119962205.ch3 |
0.373 |
|
| 2010 |
Wang CC, Kao JH. Metformin improves sustained virologic response in difficult-to-cure hepatitis C: more questions than answers. Hepatology (Baltimore, Md.). 51: 1082; author reply 1. PMID 20198629 DOI: 10.1002/hep.23546 |
0.306 |
|
| 2010 |
Hsu CS, Kao JH. Role of Viral Factors in Modifying Weight-Related Effects on Disease Progression of Chronic Hepatitis C Patients Gastroenterology. 138: 788-789. PMID 20026441 DOI: 10.1053/j.gastro.2009.09.078 |
0.342 |
|
| 2009 |
Chuang JY, Yang SS, Lu YT, Hsieh YY, Chen CY, Chang SC, Chang CS, Yeh HZ, Kao JH. IL-10 promoter gene polymorphisms and sustained response to combination therapy in Taiwanese chronic hepatitis C patients. Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association For the Study of the Liver. 41: 424-30. PMID 19004675 DOI: 10.1016/j.dld.2008.09.017 |
0.379 |
|
| 2009 |
Tseng TC, Liu CJ, Hsieh SC, Chen PJ, Lai MY, Chen DS, Kao JH. Reactivation of hepatitis B virus in an inactive hepatitis B carrier with glucocorticoid pulse therapy Digestive and Liver Disease. 41: 322-323. PMID 18848814 DOI: 10.1016/j.dld.2008.08.007 |
0.422 |
|
| 2008 |
Kao JH. Diagnosis of hepatitis B virus infection through serological and virological markers Expert Review of Gastroenterology and Hepatology. 2: 553-562. PMID 19072403 DOI: 10.1586/17474124.2.4.553 |
0.441 |
|
| 2008 |
Tseng TC, Kao JH. HBV Genotype and Clinical Outcome of Chronic Hepatitis B: Facts and Puzzles Gastroenterology. 134: 1272-1273. PMID 18395116 DOI: 10.1053/j.gastro.2007.12.046 |
0.41 |
|
| 2008 |
Lin CL, Branch RA, Kao JH. Combination of Hepatitis B Viral Factors and Advanced Liver Disease in HBeAg-Negative Patients: The More, the Worse? Gastroenterology. 134: 1270-1271. PMID 18395114 DOI: 10.1053/j.gastro.2007.12.045 |
0.61 |
|
| 2008 |
Liu CH, Liang CC, Lin JW, Chen SI, Tsai HB, Chang CS, Hung PH, Kao JH, Liu CJ, Lai MY, Chen JH, Chen PJ, Kao JH, Chen DS. Pegylated interferon alpha-2a versus standard interferon alpha-2a for treatment-naive dialysis patients with chronic hepatitis C: a randomised study. Gut. 57: 525-30. PMID 17881538 DOI: 10.1136/gut.2007.133884 |
0.343 |
|
| 2007 |
Kao JH. Role of viral factors in the natural course and therapy of chronic hepatitis B. Hepatology International. 1: 415-30. PMID 19669337 DOI: 10.1007/s12072-007-9033-2 |
0.47 |
|
| 2007 |
Lin CL, Kao JH. Viremia Profiles in Hepatitis B Virus Carrier Children With Spontaneous e Antigen Seroconversion: A Case of Déjà Vu? Gastroenterology. 133: 1052-1053. PMID 17854613 DOI: 10.1053/j.gastro.2007.07.015 |
0.543 |
|
| 2007 |
Tsai FC, Liu CJ, Chen CL, Chen PJ, Lai MY, Kao JH, Chen DS. Lower serum viral loads in young patients with hepatitis-B-virus-related hepatocellular carcinoma. Journal of Viral Hepatitis. 14: 153-60. PMID 17305880 DOI: 10.1111/j.1365-2893.2006.00780.x |
0.324 |
|
| 2007 |
Lin CL, Chen JD, Liu CJ, Lee PH, Chen PJ, Lai MY, Kao JH, Chen DS. Clinicopathological differences between hepatitis B viral genotype B- and C-related resectable hepatocellular carcinoma. Journal of Viral Hepatitis. 14: 64-9. PMID 17212646 DOI: 10.1111/j.1365-2893.2006.00776.x |
0.389 |
|
| 2007 |
Kao JH. Appropriate use of interferon for treatment of chronic hepatitis B Hepatology Research. 37. DOI: 10.1111/j.1872-034X.2007.00105.x |
0.452 |
|
| 2006 |
Liu CJ, Kao JH. Pegylated interferons for the treatment of chronic hepatitis B Recent Patents On Anti-Infective Drug Discovery. 1: 85-94. PMID 18221137 DOI: 10.2174/157489106775244154 |
0.383 |
|
| 2006 |
Liu CJ, Kao JH, Chen PJ, Chen TC, Lin FY, Lai MY, Chen DS. Overlap lamivudine treatment in patients with chronic hepatitis B receiving adefovir for lamivudine-resistant viral mutants. Journal of Viral Hepatitis. 13: 387-95. PMID 16842441 DOI: 10.1111/j.1365-2893.2005.00704.x |
0.428 |
|
| 2003 |
Kao JH. Hepatitis B virus genotypes and hepatocellular carcinoma in Taiwan Intervirology. 46: 400-407. PMID 14688459 DOI: 10.1159/000074999 |
0.439 |
|
| 2002 |
Kao JH. Hepatitis B viral genotypes: Clinical relevance and molecular characteristics Journal of Gastroenterology and Hepatology (Australia). 17: 643-650. PMID 12100608 DOI: 10.1046/j.1440-1746.2002.02737.x |
0.449 |
|
| 2002 |
Kao JH. Clinical relevance of hepatitis B viral genotypes: A case of déjà vu? Journal of Gastroenterology and Hepatology (Australia). 17: 113-115. DOI: 10.1046/j.1440-1746.2002.02623.x |
0.377 |
|
| 2001 |
Liu CJ, Lai MY, Lee PH, Chou NK, Chu SH, Chen PJ, Kao JH, Jen YM, Chen DS. Lamivudine treatment for hepatitis B reactivation in HBsAg carriers after organ transplantation: a 4-year experience. Journal of Gastroenterology and Hepatology. 16: 1001-8. PMID 11595064 DOI: 10.1046/j.1440-1746.2001.02532.x |
0.355 |
|
| 2001 |
Kao JH, Chen PJ, Lai MY, Chen DS. Acute exacerbations of chronic hepatitis B are rarely associated with superinfection of hepatitis B virus Hepatology. 34: 817-823. PMID 11584381 DOI: 10.1053/jhep.2001.28188 |
0.452 |
|
| 2001 |
Liu CJ, Chen PJ, Lai MY, Kao JH, Chen DS. Hepatitis B virus variants in patients receiving lamivudine treatment with breakthrough hepatitis evaluated by serial viral loads and full-length viral sequences Hepatology. 34: 583-589. PMID 11526546 DOI: 10.1053/jhep.2001.27220 |
0.431 |
|
| 2001 |
Kao JH, Wu NH, Chen PJ, Lai MY, Chen DS. Hepatitis B genotypes and the response to interferon therapy. Journal of Hepatology. 33: 998-1002. PMID 11131465 DOI: 10.1016/S0168-8278(00)80135-X |
0.47 |
|
| 2001 |
Chen JD, Chung JL, Kao JH, Chen DS. Post-partum acute exacerbation of chronic hepatitis in a hepatitis C-carrier mother Journal of Gastroenterology and Hepatology (Australia). 16: 705-708. DOI: 10.1046/j.1440-1746.2001.02502.x |
0.347 |
|
| 2000 |
Kao JH, Liu CJ, Chen PJ, Chen W, Lai MY, Chen DS. Low incidence of hepatitis C virus transmission between spouses: a prospective study. Journal of Gastroenterology and Hepatology. 15: 391-5. PMID 10824883 DOI: 10.1046/j.1440-1746.2000.02165.x |
0.361 |
|
| 2000 |
Kao JH, Chen PJ, Lai MY, Chen DS. Hepatitis B genotypes correlate with clinical outcomes in patients with chronic hepatitis B Gastroenterology. 118: 554-559. PMID 10702206 DOI: 10.1016/S0016-5085(00)70261-7 |
0.425 |
|
| 2000 |
Kao JH, Chen W, Chen PJ, Lai MY, Chen DS. TT virus infection in patients with chronic hepatitis B or C: influence on clinical, histological and virological features. Journal of Medical Virology. 60: 387-92. PMID 10686020 DOI: 10.1002/(SICI)1096-9071(200004)60:4<387::AID-JMV4>3.0.CO;2-Z |
0.441 |
|
| 2000 |
Kao JH, Chen PJ, Lai MY, Chen DS. Efficacy of consensus interferon in the treatment of chronic hepatitis C Journal of Gastroenterology and Hepatology (Australia). 15: 1418-1423. DOI: 10.1046/j.1440-1746.2000.02371.x |
0.349 |
|
| 1999 |
Kao JH, Heptonstall J, Chen DS. Molecular methods of measurement of hepatitis B virus, hepatitis C virus, and human immunodeficiency virus infection: Implications for occupational health practice Occupational and Environmental Medicine. 56: 730-734. PMID 10658557 DOI: 10.1136/oem.56.11.730 |
0.341 |
|
| 1999 |
Kao JH, Chen W, Hsiang SC, Chen PJ, Lai MY, Chen DS. Prevalence and implication of TT virus infection: Minimal role in patients with non-A-E hepatitis in Taiwan Journal of Medical Virology. 59: 307-312. PMID 10502261 DOI: 10.1002/(SICI)1096-9071(199911)59:3<307::AID-JMV8>3.0.CO;2-3 |
0.461 |
|
| 1999 |
Kao JH, Chen DS. GB virus-C/hepatitis G virus infection in Taiwan: A virus that fails to cause a disease? Journal of Biomedical Science. 6: 220-225. PMID 10420079 DOI: 10.1007/BF02253563 |
0.34 |
|
| 1999 |
Kao JH, Wood M, Chen PJ, Lai MY, Chen DS. Comparison of two methods for quantification of hepatitis B viral DNA. Journal of Gastroenterology and Hepatology. 14: 423-6. PMID 10355505 DOI: 10.1046/j.1440-1746.1999.01885.x |
0.361 |
|
| 1999 |
Kao JH, Huang CH, Chen W, Tsai TJ, Lee SH, Hung KY, Chen DS. GB virus C infection in hemodialysis patients: molecular evidence for nosocomial transmission. The Journal of Infectious Diseases. 180: 191-4. PMID 10353878 DOI: 10.1086/314850 |
0.332 |
|
| 1999 |
Liu CJ, Kao JH, Lai MY, Chen PJ, Chu JS, Chen W, Chen DS. Minimal role of GB virus-C/hepatitis G virus in fulminant and subfulminant hepatitis in Taiwan. Journal of Gastroenterology and Hepatology. 14: 352-7. PMID 10207785 DOI: 10.1046/j.1440-1746.1999.01855.x |
0.384 |
|
| 1997 |
Kao JH, Liu CJ, Chen PJ, Chen W, Hsiang SC, Lai MY, Chen DS. Interspousal transmission of GB virus-C/Hepatitis G virus: A comparison with hepatitis C virus Journal of Medical Virology. 53: 348-353. PMID 9407382 DOI: 10.1002/(SICI)1096-9071(199712)53:4<348::AID-JMV6>3.0.CO;2-7 |
0.307 |
|
| 1997 |
Kao JH, Chen W, Chen PJ, Lai MY, Lin RY, Chen DS. GB virus-C/hepatitis G virus infection in prostitutes: possible role of sexual transmission. Journal of Medical Virology. 52: 381-4. PMID 9260684 DOI: 10.1002/(SICI)1096-9071(199708)52:4<381::AID-JMV6>3.0.CO;2-Y |
0.33 |
|
| 1997 |
Kao JH, Chen PJ, Lai MY, Wang TH, Chen DS. Positive and negative strand of hepatitis C virus RNA sequences in peripheral blood mononuclear cells in patients with chronic hepatitis C: No correlation with viral genotypes 1b, 2a, and 2b Journal of Medical Virology. 52: 270-274. PMID 9210035 DOI: 10.1002/(SICI)1096-9071(199707)52:3<270::AID-JMV6>3.0.CO;2-# |
0.367 |
|
| 1997 |
Kao JH, Chen PJ, Lai MY, Chen W, Liu DP, Wang JT, Shen MC, Chen DS. GB virus-C/hepatitis G virus infection in an area endemic for viral hepatitis, chronic liver disease, and liver cancer. Gastroenterology. 112: 1265-70. PMID 9098011 DOI: 10.1016/S0016-5085(97)70139-2 |
0.408 |
|
| 1997 |
Kao JH, Chen PJ, Yang PM, Lai MY, Wang TH, Chen DS. Absence of extensive genetic heterogeneity of hepatitis C virus in antibody-negative chronic hepatitis C. Journal of Medical Virology. 49: 87-90. PMID 8991941 DOI: 10.1002/(SICI)1096-9071(199606)49:2<87::AID-JMV3>3.0.CO;2-F |
0.316 |
|
| 1997 |
Kao JH, Chen PJ, Wang JT, Yang PM, Lai MY, Wang TH, Chen DS. Superinfection by homotypic virus in hepatitis C virus carriers: studies on patients with post-transfusion hepatitis. Journal of Medical Virology. 50: 303-8. PMID 8950686 DOI: 10.1002/(SICI)1096-9071(199612)50:4<303::AID-JMV4>3.0.CO;2-C |
0.407 |
|
| 1997 |
Hwang YT, Chen PJ, Kao JH, Wang TD, Wang HH, Chu JS, Su IJ, Chen DS. Rapid hepatic failure associated with a contracted liver mimicking cirrhosis in a case of nasopharyngeal carcinoma with liver metastasis. Liver. 16: 283-7. PMID 8878002 DOI: 10.1111/J.1600-0676.1996.TB00744.X |
0.326 |
|
| 1997 |
Kao JH, Yang PM, Lai MY, Chen PJ, Wang TH, Chen DS. Evaluation of third-generation hepatitis C antibody assay in chronic hepatitis C and chronic non-B, non-C hepatitis. Viral Immunology. 8: 135-9. PMID 8833266 DOI: 10.1089/vim.1995.8.135 |
0.302 |
|
| 1996 |
Kao JH, Lai MY, Chen PJ, Hwang LH, Chen DS. Serum hepatitis C virus titers in the progression of type C chronic liver disease with special emphasis on patients with type 1b infection Journal of Clinical Gastroenterology. 23: 280-283. PMID 8957730 DOI: 10.1097/00004836-199612000-00008 |
0.433 |
|
| 1996 |
Chen PJ, Kao JH, Chen DS. Hepatitis G virus in intravenous immunoglobulin. Gastroenterology. 111: 1399-400. PMID 8898661 DOI: 10.1053/gast.1996.v111.agast961111399 |
0.322 |
|
| 1996 |
Lai MY, Kao JH, Yang PM, Wang JT, Chen PJ, Chan KW, Chu JS, Chen DS. Long-term efficacy of ribavirin plus interferon alfa in the treatment of chronic hepatitis C. Gastroenterology. 111: 1307-12. PMID 8898645 DOI: 10.1053/gast.1996.v111.pm8898645 |
0.359 |
|
| 1996 |
Hwang LH, Yang PM, Lai MY, Chiang BL, Kao JH, Wang JT, Lee SY, Chian HM, Chi WK, Chu YD, Chen PJ, Chen DS. Identification of humoral antigenic determinants in the hepatitis C virus NS3 protein. The Journal of Infectious Diseases. 174: 173-6. PMID 8655988 DOI: 10.1093/infdis/174.1.173 |
0.431 |
|
| 1996 |
Kao JH, Chen PJ, Lai MY, Yang PM, Sheu JC, Wang TH, Chen DS. Genotypes of hepatitis C virus in Taiwan and the progression of liver disease. Journal of Clinical Gastroenterology. 21: 233-7. PMID 8648060 DOI: 10.1097/00004836-199510000-00014 |
0.413 |
|
| 1996 |
Lin HH, Kao JH, Huang SC, Lee TY, Chen PJ, Chen DS. Prevalence, genotypes and antibody titer of hepatitis C virus in pregnant women in Taiwan. Journal of Obstetrics and Gynaecology (Tokyo, Japan). 21: 557-62. PMID 8640465 DOI: 10.1111/j.1447-0756.1995.tb00912.x |
0.305 |
|
| 1996 |
Kao JH, Lai MY, Hwang YT, Yang PM, Chen PJ, Sheu JC, Wang TH, Hsu HC, Chen DS. Chronic hepatitis C without anti-hepatitis C antibodies by second-generation assay. A clinicopathologic study and demonstration of the usefulness of a third-generation assay. Digestive Diseases and Sciences. 41: 161-5. PMID 8565750 DOI: 10.1007/BF02208599 |
0.349 |
|
| 1995 |
Kao JH, Tsai SL, Chen PJ, Yang PM, Sheu JC, Lai MY, Hsu HC, Sung JL, Wang TH, Chen DS. A clinicopathologic study of chronic non-A, non-B (type C) hepatitis in Taiwan: comparison between posttransfusion and sporadic patients. Journal of Hepatology. 21: 244-9. PMID 7989717 DOI: 10.1016/S0168-8278(05)80403-9 |
0.457 |
|
| 1995 |
Yang SS, Wu CH, Huang CS, Ho MS, Lai MY, Kao JH, Chen DS. Early interferon therapy and abortion of posttransfusion hepatitis C viral infection. Journal of Clinical Gastroenterology. 21: 38-41. PMID 7560832 DOI: 10.1097/00004836-199507000-00010 |
0.351 |
|
| 1995 |
Yang PM, Hwang LH, Lai MY, Huang WL, Chu YD, Chi WK, Chiang BL, Kao JH, Chen PJ, Chen DS. Prominent proliferative response of peripheral blood mononuclear cells to a recombinant non-structural (NS3) protein of hepatitis C virus in patients with chronic hepatitis C. Clinical and Experimental Immunology. 101: 272-7. PMID 7544249 DOI: 10.1111/j.1365-2249.1995.tb08350.x |
0.408 |
|
| 1995 |
Tsai SL, Chen PJ, Hwang LH, Kao JH, Huang JH, Chang TH, Chen DS. Immune response to a hepatitis C virus nonstructural protein in chronic hepatitis C virus infection. Journal of Hepatology. 21: 403-11. PMID 7530738 DOI: 10.1016/S0168-8278(05)80320-4 |
0.313 |
|
| 1995 |
KAO J. P-37 Quasispecies of hepatitis C virus and genetic drift of the hypervariable region in chronic type C hepatitis International Hepatology Communications. 3: S46. DOI: 10.1016/0928-4346(95)90336-6 |
0.357 |
|
| 1994 |
Kao JH, Chen PJ, Lai MY, Yang PM, Sheu JC, Wang TH, Chen DS. Mixed infections of hepatitis C virus as a factor in acute exacerbations of chronic type C hepatitis. The Journal of Infectious Diseases. 170: 1128-33. PMID 7963704 DOI: 10.1093/infdis/170.5.1128 |
0.381 |
|
| 1993 |
Kao JH, Chen PJ, Lai MY, Chen DS. Superinfection of heterologous hepatitis C virus in a patient with chronic type C hepatitis Gastroenterology. 105: 583-587. PMID 8392958 DOI: 10.1016/0016-5085(93)90737-W |
0.324 |
|
| 1992 |
Kao JH, Chen PJ, Yang PM, Lai MY, Sheu JC, Wang TH, Chen DS. Intrafamilial transmission of hepatitis C virus: the important role of infections between spouses. The Journal of Infectious Diseases. 166: 900-3. PMID 1382107 DOI: 10.1093/infdis/166.4.900 |
0.309 |
|
| Show low-probability matches. |